Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


30.01.2017

2 Am J Clin Pathol
2 Am J Hematol
11 Ann Hematol
10 Blood
1 BMC Cancer
2 Bone Marrow Transplant
2 Cancer
2 Cancer Res
2 Eur J Haematol
1 Int J Hematol
2 J Clin Oncol
2 Leuk Lymphoma
4 Leuk Res
6 Leukemia
1 Oncogene
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. DAYTON VJ, McKenna RW, Yohe SL, Dolan MM, et al
    Relapsed Acute Promyelocytic Leukemia Lacks "Classic" Leukemic Promyelocyte Morphology and Can Create Diagnostic Challenges.
    Am J Clin Pathol. 2017 Jan 20. pii: aqw202. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. KOVACH AE, Brunner AM, Fathi AT, Chen YB, et al
    Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.
    Am J Clin Pathol. 2017 Jan 20. pii: aqw203. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Hematol

  3. DELGADO J, Doubek M, Baumann T, Kotaskova J, et al
    Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Am J Hematol. 2017 Jan 25. doi: 10.1002/ajh.24660.
    PubMed     Text format     Abstract available

  4. JAYAKAR V, Cheung K, Yebra-Fernandez E, Bain BJ, et al
    The distinctive cytological features of T-cell prolymphocytic leukemia.
    Am J Hematol. 2017 Jan 25. doi: 10.1002/ajh.24659.
    PubMed     Text format    


    Ann Hematol

  5. MOLLOY C, Cahill R, Gallagher D, Murphy P, et al
    Early-onset chronic lymphocytic leukaemia in a young man with Cowden syndrome.
    Ann Hematol. 2016;95:1205-6.
    PubMed     Text format    

  6. MLIKA M, Khanfir D, Mansouri R, El Mezni F, et al
    Multivariate analysis of prognostic factors of lymphoblastic lymphomas of the mediastinum.
    Ann Hematol. 2016;95:1731-2.
    PubMed     Text format    

  7. WU W, Lin Y, Xiang L, Dong W, et al
    Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy.
    Ann Hematol. 2016;95:1051-7.
    PubMed     Text format     Abstract available

  8. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    PubMed     Text format     Abstract available

  9. ERNST J, Schafer V, Rinke J, Wittig S, et al
    Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML.
    Ann Hematol. 2016;95:1027-30.
    PubMed     Text format    

  10. WU SJ, Lin CT, Lin SC, Hsieh PY, et al
    Similar epidemiological trends of pre-neoplastic precursors and their respective lymphoid malignancies in Taiwan.
    Ann Hematol. 2016;95:1727-9.
    PubMed     Text format    

  11. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    PubMed     Text format     Abstract available

  12. KOURIE HR, Ameye L, Paesmans M, Bron D, et al
    Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
    Ann Hematol. 2016;95:2105-2106.
    PubMed     Text format    

  13. CATTANEO C, Zappasodi P, Mancini V, Annaloro C, et al
    Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).
    Ann Hematol. 2016;95:1955-1963.
    PubMed     Text format     Abstract available

  14. HAERZSCHEL A, Catusse J, Hutterer E, Paunovic M, et al
    BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Ann Hematol. 2016;95:1979-1988.
    PubMed     Text format     Abstract available

  15. DAI Z, Feng C, Zhang W, Liu J, et al
    Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis.
    Ann Hematol. 2016;95:1685-94.
    PubMed     Text format     Abstract available


    Blood

  16. LANOCHA AA, Zdziarska B
    T-cell lymphoblastic leukemia with t(11;22)(q24;q12) and EWSR1 rearrangement.
    Blood. 2017;129:393.
    PubMed     Text format    

  17. FINCH ER, Tukaramrao DB, Goodfield LL, Quickel MD, et al
    Activation of PPARgamma by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-08-736405. doi: 10.1182/blood-2016-08-736405
    PubMed     Text format     Abstract available

  18. WATANABE T
    Adult T-cell leukemia (ATL): molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
    Blood. 2017 Jan 23. pii: blood-2016-09-692574. doi: 10.1182/blood-2016-09-692574
    PubMed     Text format     Abstract available

  19. LAMY T, Moignet A, Loughran TP Jr
    LGL leukemia: from pathogenesis to treatment.
    Blood. 2017 Jan 23. pii: blood-2016-08-692590. doi: 10.1182/blood-2016-08-692590
    PubMed     Text format     Abstract available

  20. SANCHEZ-MARTIN M, Ferrando A
    The NOTCH1-MYC highway towards T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-09-692582. doi: 10.1182/blood-2016-09-692582
    PubMed     Text format     Abstract available

  21. MARKS DI, Rowntree C
    A review of the management of adults with T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-07-692608. doi: 10.1182/blood-2016-07-692608
    PubMed     Text format     Abstract available

  22. BOCHTLER T, Granzow M, Stolzel F, Kunz C, et al
    Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
    Blood. 2017 Jan 24. pii: blood-2016-09-738161. doi: 10.1182/blood-2016-09-738161
    PubMed     Text format     Abstract available

  23. PYZER AR, Stroopinsky D, Rajabi H, Washington A, et al
    MUC1 mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-07-730614. doi: 10.1182/blood-2016-07-730614
    PubMed     Text format     Abstract available

  24. GHIA P, Scarfo L, Perez S, Pathiraja K, et al
    Efficacy and safety of dinaciclib versus ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-10-748210. doi: 10.1182/blood-2016-10-748210
    PubMed     Text format    

  25. XU J, Li S
    Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
    Blood. 2017;129:537.
    PubMed     Text format    


    BMC Cancer

  26. PENG HX, Liu XD, Luo ZY, Zhang XH, et al
    Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.
    BMC Cancer. 2017;17:76.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  27. ROUX C, Tifratene K, Socie G, Galambrun C, et al
    Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the societe Francophone de greffe de moelle et de therapie cellulaire (SFGM-TC).
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available

  28. YANADA M, Kurosawa S, Kobayashi T, Ozawa Y, et al
    Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    Cancer

  29. MICHELIS FV, Gupta V, Zhang MJ, Wang HL, et al
    Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30567.
    PubMed     Text format     Abstract available

  30. WEISDORF DJ, Millard HR, Horowitz MM, Hyare PS, et al
    Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30536.
    PubMed     Text format     Abstract available


    Cancer Res

  31. TABE Y, Yamamoto S, Saitoh K, Sekihara K, et al
    Survival of acute monocytic leukemia cells is driven by fatty acid oxidation-mediated activation of AMPK in bone marrow adipocytes.
    Cancer Res. 2017 Jan 20. pii: canres.1645.2016.
    PubMed     Text format     Abstract available

  32. GAYMES TJ, Mohamedali A, Eiliazadeh A, Darling D, et al
    FLT3 and JAK2 mutations in acute myeloid leukemia promote inter-chromosomal homologous recombination and the potential for copy neutral loss of heterozygosity (CN-LOH).
    Cancer Res. 2017 Jan 20. pii: canres.1678.2016.
    PubMed     Text format     Abstract available


    Eur J Haematol

  33. MORI N, Ohwashi-Miyazaki M, Yoshinaga K, Okada M, et al
    Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia.
    Eur J Haematol. 2017 Jan 27. doi: 10.1111/ejh.12857.
    PubMed     Text format     Abstract available

  34. CAHU X, Carre M, Recher C, Pigneux A, et al
    Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
    Eur J Haematol. 2017 Jan 25. doi: 10.1111/ejh.12850.
    PubMed     Text format     Abstract available


    Int J Hematol

  35. ANDO T, Yamazaki E, Ogusa E, Ishii Y, et al
    Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
    Int J Hematol. 2017 Jan 21. doi: 10.1007/s12185-017-2183.
    PubMed     Text format     Abstract available


    J Clin Oncol

  36. JURCIC JG
    Androgen Maintenance Therapy for Acute Myeloid Leukemia.
    J Clin Oncol. 2017;35:381-383.
    PubMed     Text format    

  37. PIGNEUX A, Bene MC, Guardiola P, Recher C, et al
    Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study.
    J Clin Oncol. 2017;35:387-393.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  38. CRAMPE M, Shakkak F, Kelly J, Hodgson A, et al
    Chronic myeloid leukemia with a novel e8a1 BCR-ABL1 fusion: rapid molecular response with nilotinib.
    Leuk Lymphoma. 2017 Jan 25:1-6. doi: 10.1080/10428194.2017.1281413.
    PubMed     Text format    

  39. HOLKOVA B, Yazbeck V, Kmieciak M, Bose P, et al
    A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma.
    Leuk Lymphoma. 2017 Jan 19:1-9. doi: 10.1080/10428194.2016.1276287.
    PubMed     Text format     Abstract available


    Leuk Res

  40. HATTORI A, McSkimming D, Kannan N, Ito T, et al
    RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia.
    Leuk Res. 2017;54:47-54.
    PubMed     Text format     Abstract available

  41. IRIYAMA N, Tokuhira M, Takaku T, Sato E, et al
    Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group.
    Leuk Res. 2017;54:55-58.
    PubMed     Text format     Abstract available

  42. PORTICH JP, Dos Santos RP, Kersting N, Jorge KB, et al
    DNA damage response in patients with pediatric Acute Lymphoid Leukemia during induction therapy.
    Leuk Res. 2017;54:59-65.
    PubMed     Text format     Abstract available

  43. JEVTOVIC-STOIMENOV T, Cvetkovic T, Despotovic M, Basic J, et al
    The influence of TNF alpha -308 G/A polymorphism on oxidative stress in patients with chronic lymphocytic leukemia.
    Leuk Res. 2017;54:66-72.
    PubMed     Text format     Abstract available


    Leukemia

  44. RECKEL S, Hamelin R, Georgeon S, Armand F, et al
    Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.
    Leukemia. 2017 Jan 23. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  45. ROSSIG C, Pule M, Altvater B, Saiagh S, et al
    Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.
    Leukemia. 2017 Jan 27. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  46. BRUNETTI L, Di Battista V, Venanzi A, Schiavoni G, et al
    Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin.
    Leukemia. 2017 Jan 23. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  47. MURPHY EJ, Neuberg DS, Rassenti LZ, Hayes G, et al
    Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.
    Leukemia. 2017 Jan 24. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  48. GUIDUGLI L, Johnson AK, Alkorta-Aranburu G, Nelakuditi V, et al
    Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.
    Leukemia. 2017 Jan 20. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  49. DENG J, Isik E, Fernandes SM, Brown JR, et al
    Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.
    Leukemia. 2017 Jan 23. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncogene

  50. PRANGE KH, Mandoli A, Kuznetsova T, Wang SY, et al
    MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    PLoS One

  51. KREIS C, Lupatsch JE, Niggli F, Egger M, et al
    Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion.
    PLoS One. 2017;12:e0170020.
    PubMed     Text format     Abstract available

  52. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Text format     Abstract available

  53. YANG L, Sun H, Cao Y, Xuan B, et al
    GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
    PLoS One. 2017;12:e0170630.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: